Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2005
08/02/2005US6924362 Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C
08/02/2005US6924360 Antitumor agents
08/02/2005US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
08/02/2005US6924356 Human protein HHEPU32
08/02/2005US6924126 Cloning, expression and characterization of the SPG4 gene responsible for the most frequent form of autosomal spastic paraplegia
08/02/2005US6924124 Feeding strategies for cell culture
08/02/2005US6924121 Sperm specific proteins
08/02/2005US6924120 sequence linked to a target protein, preferably an insulin precursor; present invention also relates to a process for obtaining a correctly folded insulin-precursor
08/02/2005US6924117 Human RRP sequences and methods of use
08/02/2005US6924110 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/02/2005US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches
08/02/2005US6924097 Plant promoter and method for gene expression using said promoter
08/02/2005CA2343586C Modified green fluorescent proteins
08/02/2005CA2078539C Process for producing humanized chimera antibody
07/2005
07/28/2005WO2005068646A1 Methods for the protein production and purification of soluble recombinant polypeptides
07/28/2005WO2005068622A2 Mixtures of binding proteins
07/28/2005WO2005068620A1 Method for the production of recombinant proteins
07/28/2005WO2005068489A1 Process for producing human serum albumin by heating in presence of divalent cation
07/28/2005WO2005067478A2 Recombinant icosahedral virus like particle production in pseudomonads
07/28/2005WO2005054438A3 Nucleic acid molecules containing recombination sites and methods of using the same
07/28/2005WO2005041880A3 RhPV AS A MODEL FOR HPV-INDUCED CANCERS
07/28/2005WO2005029452A3 Segmented character display
07/28/2005WO2005025516A3 Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates
07/28/2005WO2005017102A3 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
07/28/2005WO2005004793A3 Compositions and methods for treating coagulation related disorders
07/28/2005WO2005003289A3 Ap1 amine oxidase variants
07/28/2005WO2004108895A3 Humanized antibodies that recognize beta amyloid peptide
07/28/2005WO2003072035A8 Compositions and methods for the treatment of immune related diseases
07/28/2005US20050166274 Compositions and methods for the diagnosis and treatment of tumor
07/28/2005US20050165223 Immunoglobulin for use in diagnosis, prevention and treatment of nervous system and neurodegenerative disorders
07/28/2005US20050165219 Related to the thymic stromal cotransporter subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
07/28/2005US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis
07/28/2005US20050164926 Novel recombinant anticoagulant proteins
07/28/2005US20050164917 Methods and means for producing proteins with predetermined post-translational modifications
07/28/2005US20050164392 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells
07/28/2005US20050164367 Protein
07/28/2005US20050164352 Immunoglobulin interleukin fusion for activating lymphoid precursor cells; treatment and prevention of infection
07/28/2005US20050164349 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex
07/28/2005US20050164339 Purified enzyme mixture capable of effecting dehydration and cyclization of precursor peptide; medicines; food processing; bioagriculture; drugs and cytotoxicity
07/28/2005US20050164338 Helicobacter; for production of oligosaccharides, glycoproteins, and glycolipids
07/28/2005US20050164337 Using metal affinity chromatography to isolate beta -conglycinin-enriched soluble protein fraction for use in treatment of hyperlipidemias; anticholesterol agents
07/28/2005US20050164325 Method of mass spectrometry
07/28/2005US20050164313 Methods and compositions for the detection of cervical cancer
07/28/2005US20050164310 Using voltage sensitive dyes to identifying modulators of G-protein sensory signaling; immunoassay; customizing taste of foods and/or medicines
07/28/2005US20050164307 Methods of screening agonistic antibody
07/28/2005US20050164303 Specific-C-peptide assay method
07/28/2005US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders
07/28/2005US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same
07/28/2005US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/28/2005US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid
07/28/2005US20050164239 Optical sorting method
07/28/2005US20050164232 Reg-like protein
07/28/2005US20050164201 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof
07/28/2005US20050164194 Growth regulating proteins
07/28/2005US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/28/2005US20050164178 Starch branching enzyme
07/28/2005US20050163794 Immunological herpes simplex virus antigens and methods for use thereof
07/28/2005US20050163793 Methods for recovering peptides from stress protein-peptide complexes
07/28/2005US20050163792 Stress protein joined to another component, such as a fusion protein in which a stress protein is fused to an antigen
07/28/2005US20050163779 smooth muscle growth inhibitory composition comprising adipose tissue-specific secretory factor apM1 (adipose most abundant gene transcript 1) as an active ingredient; diagnostic agent comprising an antibody against the adipose tissue-specific secretory factor apM1
07/28/2005US20050163772 B7S1: an immune modulator
07/28/2005US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain
07/28/2005US20050163766 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/28/2005US20050163747 Heteromultimeric TNF ligand family members
07/28/2005US20050163709 Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
07/28/2005CA2559379A1 Process for producing human serum albumin by heating in presence of divalent cation
07/28/2005CA2554054A1 Mixtures of binding proteins
07/28/2005CA2554001A1 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
07/28/2005CA2553807A1 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters
07/28/2005CA2551126A1 Toxin complex proteins and genes from xenorhabdus bovienii
07/28/2005CA2547511A1 Recombinant icosahedral virus like particle production in pseudomonads
07/28/2005CA2546319A1 Production of glucagon like peptide 2 and analogs
07/27/2005EP1557431A1 Assay and reagents for quantifying hBNP
07/27/2005EP1557430A1 Antibody and utilization of the same
07/27/2005EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them
07/27/2005EP1557173A1 Soluble CTLA4 mutant molecules and uses thereof
07/27/2005EP1556694A2 Method of isolation and self-assembly of small protein particles from blood and other biological materials
07/27/2005EP1556499A2 Monoclonal antibodies specific for cariogenic bacteria
07/27/2005EP1556480A2 Method for isolating and culturing unculturable microorganisms
07/27/2005EP1556401A2 22 human secreted proteins
07/27/2005EP1556069A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors
07/27/2005EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods
07/27/2005EP0990000B1 Connective tissue growth factor-3
07/27/2005EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS
07/27/2005EP0682707B1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
07/27/2005CN1646916A Compositions, methods and kits for immunochemical determination of mannan-binding lectin (MBL)
07/27/2005CN1646694A Over-expression of extremozyme genes in pseudomonads and closely related bacteria
07/27/2005CN1646689A Novel scavenger receptors
07/27/2005CN1646688A Growth regulating proteins
07/27/2005CN1646683A Host cells having improved cell survival properties and methods to generate such cells
07/27/2005CN1646681A Cell culture medium
07/27/2005CN1646564A 修饰的因子Ⅷ Modification factor Ⅷ
07/27/2005CN1646161A Reagents and treatment methods for autoimmune diseases
07/27/2005CN1646154A Albumin-fused anti-angiogenesis peptides
07/27/2005CN1644708A Mycobacterium tuberculosis superoxide dismutase
07/27/2005CN1644693A Protein having tpo activity
07/27/2005CN1212337C Tumour nascent blood ressel specificity conjugated polypeptide and human alpha interferon fusion protein and preparation
07/27/2005CN1212336C Prepn. of recombinant human parathyroid hormone PTH(1-34)
07/27/2005CN1212334C Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use
07/26/2005US6921809 Immunoglobulin conjugate comprising amino acid sequences from dihydrolipoamide dehydrogenase (P64K) for use as tool in immunodetection of heterologous protein expression; vaccine development